| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | +14.21% | -0.72% | +14.93% | +14.93% | — |
| 14d | 1 | +100.00% | +3.28% | +0.73% | +2.55% | +2.55% | — |
| 30d | 1 | +0.00% | -10.93% | -1.25% | -9.68% | -9.68% | — |
| 60d | 1 | +0.00% | -7.10% | -3.09% | -4.01% | -4.01% | — |
| 90d | 1 | +0.00% | -10.38% | +0.59% | -10.98% | -10.98% | — |
| 180d | 1(1 pending) | — | — | — | — | — | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 46,167 | — | — | 67,150 | May 18, 2026 | May 20, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 132,925 | — | — | 132,925 | Mar 1, 2026 | Mar 3, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 8,832 | $1.70 | $15.0K | 20,983 | Jan 14, 2026 | Jan 16, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,164 | $1.26 | $1.5K | 12,151 | Aug 1, 2025 | Aug 5, 2025 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 35,209 | — | — | 35,209 | Apr 1, 2025 | Apr 3, 2025 ↗ | View → |